Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator's demand for a local safety and immunogenicity study.
reuters.com
100% #yourbodyyourchoice #seektruth #doyourownresearch
IT WROTE ITSELF.
youtu.be
To earn tokens and access the decentralized web, select an option below
(It's easier than you think)